CITATION — REFERENCE ENTRY

ult-indications · fitzgerald-2020-acr-gout-guideline

Revision cf251e4d-8c3c-4a72-ac99-d3c678c98ce7 · 9/26/2026, 8:23:59 PM UTC
Claim ID
ult-indications
Assertion
The ACR strongly recommends starting urate-lowering therapy for patients with one or more subcutaneous tophi, radiographic joint damage due to gout, or two or more flares a year.
Quote
Initiating ULT is strongly recommended for gout patients with any of the following: ≥1 subcutaneous tophi; evidence of radiographic damage (any modality) attributable to gout; OR frequent gout flares, with frequent being defined as ≥2 annually.
Quote language
en
Locator
section: Indications for pharmacologic ULT
Available in